140 related articles for article (PubMed ID: 32680816)
1. Bevacizumab Does Not Influence the Efficacy of Partial Splenic Embolization in the Management of Chemotherapy-Induced Hypersplenism.
Jácome AA; Ohinata A; Mahvash A; Overman MJ; Kee B; Fogelman D; Morris VK; Johnson B; Rothschild ND; Wolff RA; Eng C
Clin Colorectal Cancer; 2020 Dec; 19(4):e189-e199. PubMed ID: 32680816
[TBL] [Abstract][Full Text] [Related]
2. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of partial splenic embolization for hypersplenism in pre- and post-liver transplant patients: A 16-year comparative analysis.
DuBois B; Mobley D; Chick JFB; Srinivasa RN; Wilcox C; Weintraub J
Clin Imaging; 2019; 54():71-77. PubMed ID: 30553121
[TBL] [Abstract][Full Text] [Related]
4. Partial splenic embolization in the treatment of prolonged thrombocytopenia due to hypersplenism in metastatic cancer patients.
Passhak M; Shachar SS; Ofer A; Beny A
Support Care Cancer; 2018 Oct; 26(10):3527-3532. PubMed ID: 29696427
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis.
Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Ishiko T; Baba H
J Gastroenterol; 2010 May; 45(5):554-9. PubMed ID: 20047119
[TBL] [Abstract][Full Text] [Related]
6. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.
Chikamori F; Kuniyoshi N; Kawashima T; Takase Y
Hepatogastroenterology; 2007 Sep; 54(78):1847-9. PubMed ID: 18019732
[TBL] [Abstract][Full Text] [Related]
7. Comparison of total splenic artery embolization and partial splenic embolization for hypersplenism.
He XH; Gu JJ; Li WT; Peng WJ; Li GD; Wang SP; Xu LC; Ji J
World J Gastroenterol; 2012 Jun; 18(24):3138-44. PubMed ID: 22791950
[TBL] [Abstract][Full Text] [Related]
8. Partial splenic embolization for cancer patients with thrombocytopenia requiring systemic chemotherapy.
Kauffman CR; Mahvash A; Kopetz S; Wolff RA; Ensor J; Wallace MJ
Cancer; 2008 May; 112(10):2283-8. PubMed ID: 18344210
[TBL] [Abstract][Full Text] [Related]
9. Successful management of thrombocytopenia by partial splenic embolization in patients with advanced gastric cancer and invasion of the splenic vein: Case reports.
Nakatsubo R; Yamauchi Y; Hiraizumi T; Naruse F; Kanda R; Suzuki Y; Kakegawa T; Kurosawa T; Yoshimasu Y; Saguchi T; Sofuni A; Itoi T
Medicine (Baltimore); 2021 Jul; 100(28):e26651. PubMed ID: 34260567
[TBL] [Abstract][Full Text] [Related]
10. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of partial splenic embolization in telaprevir-based triple therapy for chronic hepatitis C.
Kondo C; Atsukawa M; Tsubota A; Shimada N; Abe H; Itokawa N; Nakagawa A; Fukuda T; Matsushita Y; Nakatsuka K; Kawamoto C; Iwakiri K; Aizawa Y; Sakamoto C
Intern Med; 2015; 54(2):119-26. PubMed ID: 25743001
[TBL] [Abstract][Full Text] [Related]
12. Successful Treatment of Hypersplenism in Wilson's Disease by Partial Splenic Embolization.
Li LY; Chen HZ; Bao YC; Yu QS; Yang WM
J Invest Surg; 2018 Apr; 31(2):75-81. PubMed ID: 28135891
[TBL] [Abstract][Full Text] [Related]
13. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients.
N'Kontchou G; Seror O; Bourcier V; Mohand D; Ajavon Y; Castera L; Grando-Lemaire V; Ganne-Carrie N; Sellier N; Trinchet JC; Beaugrand M
Eur J Gastroenterol Hepatol; 2005 Feb; 17(2):179-84. PubMed ID: 15674095
[TBL] [Abstract][Full Text] [Related]
14. Partial splenic embolization with Glubran
Loffroy R; Falvo N; Nakaï M; Pescatori L; Aho-Gléglé S; Gehin S; Berthod PE; Né R; Vincent J; Ghiringhelli F; Midulla M; Chevallier O
Quant Imaging Med Surg; 2019 Mar; 9(3):409-417. PubMed ID: 31032188
[TBL] [Abstract][Full Text] [Related]
15. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
[TBL] [Abstract][Full Text] [Related]
16. Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.
Amin MA; el-Gendy MM; Dawoud IE; Shoma A; Negm AM; Amer TA
World J Surg; 2009 Aug; 33(8):1702-10. PubMed ID: 19513783
[TBL] [Abstract][Full Text] [Related]
17. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients.
Han MJ; Zhao HG; Ren K; Zhao DC; Xu K; Zhang XT
Cardiovasc Intervent Radiol; 1997; 20(2):125-7. PubMed ID: 9030503
[TBL] [Abstract][Full Text] [Related]
18. A new volumetric evaluation of partial splenic embolization for hypersplenism in biliary atresia.
Obatake M; Muraji T; Kanegawa K; Satoh S; Nishijima E; Tsugawa C
J Pediatr Surg; 2001 Nov; 36(11):1615-6. PubMed ID: 11685685
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension.
Ozturk O; Eldem G; Peynircioglu B; Kav T; Görmez A; Cil BE; Balkancı F; Sokmensuer C; Bayraktar Y
World J Gastroenterol; 2016 Nov; 22(43):9623-9630. PubMed ID: 27920483
[TBL] [Abstract][Full Text] [Related]
20. Safe use of pegylated interferon/ribavirin in hepatitis C virus cirrhotic patients with hypersplenism after partial splenic embolization.
Foruny JR; Blázquez J; Moreno A; Bárcena R; Gil-Grande L; Quereda C; Pérez-Elías MJ; Moreno J; Sánchez J; Muriel A; Rodriguez-Sagrado MA; Moreno S
Eur J Gastroenterol Hepatol; 2005 Nov; 17(11):1157-64. PubMed ID: 16215426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
